Literature DB >> 16014313

P50 inhibitory gating deficit is correlated with the negative symptomatology of schizophrenia.

Sandrine Louchart-de la Chapelle1, Daniel Levillain, Jean-François Ménard, Alexis Van der Elst, Gabrielle Allio, Sadeq Haouzir, Sonia Dollfus, Dominique Campion, Florence Thibaut.   

Abstract

Abnormal sensory gating in schizophrenia has frequently been reported. The strength of central inhibitory pathways was measured using the P50 component of the auditory evoked potential in a conditioning-testing paradigm. The relationships between a relative decrease in P50 amplitude to repeated auditory stimuli and clinical symptoms remain controversial. Using the Positive and Negative Syndrome Scale, we studied the P50 auditory conditioning-testing paradigm in 81 schizophrenic subjects, categorized into subgroups with and without prominent negative symptoms, in comparison with 88 control subjects. We found increased ratios of testing stimuli to conditioning stimuli in both schizophrenic subgroups relative to findings in the control group. In addition, we found significantly increased mean latencies of the P50 responses to conditioning (C) and testing (T) stimuli and significantly increased T/C ratios in the subgroup with negative symptoms compared with the subgroup with non-negative symptoms.

Entities:  

Mesh:

Year:  2005        PMID: 16014313     DOI: 10.1016/j.psychres.2003.04.001

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

Review 1.  Translational research in central nervous system drug discovery.

Authors:  Orest Hurko; John L Ryan
Journal:  NeuroRx       Date:  2005-10

2.  Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia.

Authors:  Holly K Hamilton; Terrance J Williams; Joseph Ventura; Leland J Jasperse; Emily M Owens; Gregory A Miller; Kenneth L Subotnik; Keith H Nuechterlein; Cindy M Yee
Journal:  Am J Psychiatry       Date:  2017-12-05       Impact factor: 18.112

Review 3.  Influence of emotional states on inhibitory gating: animals models to clinical neurophysiology.

Authors:  Howard C Cromwell; Rachel M Atchley
Journal:  Behav Brain Res       Date:  2014-05-23       Impact factor: 3.332

4.  Abnormal auditory sensory gating-out in first-episode and never-medicated paranoid schizophrenia patients: an fMRI study.

Authors:  Bin Ji; Wei Mei; John X Zhang; Juzhen Jing; Qiulin Wu; Yongning Zhuo; Zhuangwei Xiao
Journal:  Exp Brain Res       Date:  2013-07-03       Impact factor: 1.972

5.  Functional imaging of the hemodynamic sensory gating response in schizophrenia.

Authors:  Andrew R Mayer; David Ruhl; Flannery Merideth; Josef Ling; Faith M Hanlon; Juan Bustillo; Jose Cañive
Journal:  Hum Brain Mapp       Date:  2012-03-28       Impact factor: 5.038

6.  Single unit and population responses during inhibitory gating of striatal activity in freely moving rats.

Authors:  H C Cromwell; A Klein; R P Mears
Journal:  Neuroscience       Date:  2007-02-22       Impact factor: 3.590

7.  Sensory-gating deficit of the N100 mid-latency auditory evoked potential in medicated schizophrenia patients.

Authors:  Nash N Boutros; Anke Brockhaus-Dumke; Klevest Gjini; Andrei Vedeniapin; Mohamad Elfakhani; Scott Burroughs; Matcheri Keshavan
Journal:  Schizophr Res       Date:  2009-06-12       Impact factor: 4.939

8.  Positive and Negative Symptoms in Schizophrenia Relate to Distinct Oscillatory Signatures of Sensory Gating.

Authors:  Julian Keil; Yadira Roa Romero; Johanna Balz; Melissa Henjes; Daniel Senkowski
Journal:  Front Hum Neurosci       Date:  2016-03-14       Impact factor: 3.169

Review 9.  Sensory disturbances, inhibitory deficits, and the P50 wave in schizophrenia.

Authors:  Premysl Vlcek; Petr Bob; Jiri Raboch
Journal:  Neuropsychiatr Dis Treat       Date:  2014-07-14       Impact factor: 2.570

10.  P50, N100, and P200 Auditory Sensory Gating Deficits in Schizophrenia Patients.

Authors:  Chen-Lan Shen; Tai-Li Chou; Wen-Sung Lai; Ming H Hsieh; Chen-Chung Liu; Chih-Min Liu; Hai-Gwo Hwu
Journal:  Front Psychiatry       Date:  2020-08-27       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.